Guru Ownership Trend
Guru Analysis for Belite Bio, Inc (BLTE)
Belite Bio, Inc (BLTE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $23.02 M.
Top institutional holders include Stanley Druckenmiller and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $20.04 M net outflow during the quarter.
Recent activity highlights Stanley Druckenmiller who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Belite Bio, Inc (BLTE)
Major holders include Stanley Druckenmiller ($16.92 M), Renaissance Technologies (RenTech) ($8.29 M), Paul Tudor Jones ($254,466). According to the latest reported data, 3 tracked investment managers collectively hold approximately 159,696 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $20.04 M, with 3 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited BLTE. The total reported sell value was $45.5 M.
Yes, 3 managers opened new positions in BLTE, and 0 increased their existing holdings. The total reported buy value was $25.46 M.